---
document_datetime: 2025-11-23 14:21:17
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/medicines/human/EPAR/repso.html
document_name: repso.html
version: success
processing_time: 0.1203997
conversion_datetime: 2025-12-25 00:09:58.676524
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
# Repso

[RSS](/en/individual-human-medicine.xml/65878)

##### Withdrawn

This medicine's authorisation has been withdrawn

leflunomide

Medicine

Human

Withdrawn

Page contents

## Page contents

- [Overview](#overview)
- [Product information](#product-info)
- [Product details](#product-details)
- [Authorisation details](#authorisation-details)
- [Assessment history](#assessment-history)

- Application under evaluation
- CHMP opinion
- European Commission decision

## Overview

On 19 July 2017, the European Commission withdrew the marketing authorisation for Repso (leflunomide) in the European Union (EU). The withdrawal was at the request of the marketing authorisation holder, Teva B.V., which notified the European Commission of its decision to permanently discontinue the marketing of the product for commercial reasons.

Repso was granted marketing authorisation in the EU on 14 March 2011 for the treatment of active rheumatoid and active psoriatic arthritis. The marketing authorisation was initially valid for a 5-year period. It was then granted unlimited validity in 2016. Repso is a generic medicine of Arava. There are other generic medicinal products of Arava authorised and marketed in the EU.

The European Public Assessment Report (EPAR) for Repso is updated accordingly to reflect the fact that the marketing authorisation is no longer valid.

Repso : EPAR - Summary for the public

Reference Number: EMA/149379/2011

English (EN) (518.68 KB - PDF)

**First published:** 28/03/2011

**Last updated:** 28/03/2011

[View](/en/documents/overview/repso-epar-summary-public_en.pdf)

[Other languages (21)](#file-language-dropdown-244)

български (BG) (659.32 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/bg/documents/overview/repso-epar-summary-public_bg.pdf)

español (ES) (584.1 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/es/documents/overview/repso-epar-summary-public_es.pdf)

čeština (CS) (636.98 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/cs/documents/overview/repso-epar-summary-public_cs.pdf)

dansk (DA) (583.56 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/da/documents/overview/repso-epar-summary-public_da.pdf)

Deutsch (DE) (583.96 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/de/documents/overview/repso-epar-summary-public_de.pdf)

eesti keel (ET) (583.11 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/et/documents/overview/repso-epar-summary-public_et.pdf)

ελληνικά (EL) (605.52 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/el/documents/overview/repso-epar-summary-public_el.pdf)

français (FR) (588.92 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/fr/documents/overview/repso-epar-summary-public_fr.pdf)

italiano (IT) (123 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/it/documents/overview/repso-epar-summary-public_it.pdf)

latviešu valoda (LV) (640.91 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/lv/documents/overview/repso-epar-summary-public_lv.pdf)

lietuvių kalba (LT) (1.05 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/lt/documents/overview/repso-epar-summary-public_lt.pdf)

magyar (HU) (629.98 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/hu/documents/overview/repso-epar-summary-public_hu.pdf)

Malti (MT) (663.13 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/mt/documents/overview/repso-epar-summary-public_mt.pdf)

Nederlands (NL) (587.62 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/nl/documents/overview/repso-epar-summary-public_nl.pdf)

polski (PL) (637.79 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/pl/documents/overview/repso-epar-summary-public_pl.pdf)

português (PT) (584.81 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/pt/documents/overview/repso-epar-summary-public_pt.pdf)

română (RO) (609.27 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/ro/documents/overview/repso-epar-summary-public_ro.pdf)

slovenčina (SK) (633.81 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/sk/documents/overview/repso-epar-summary-public_sk.pdf)

slovenščina (SL) (630.03 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/sl/documents/overview/repso-epar-summary-public_sl.pdf)

Suomi (FI) (583.06 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/fi/documents/overview/repso-epar-summary-public_fi.pdf)

svenska (SV) (599.02 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/sv/documents/overview/repso-epar-summary-public_sv.pdf)

## Product information

Repso : EPAR - Product Information

English (EN) (994.53 KB - PDF)

**First published:** 28/03/2011

**Last updated:** 21/04/2016

[View](/en/documents/product-information/repso-epar-product-information_en.pdf)

[Other languages (24)](#file-language-dropdown-559)

български (BG) (2.12 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/bg/documents/product-information/repso-epar-product-information_bg.pdf)

español (ES) (1.07 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/es/documents/product-information/repso-epar-product-information_es.pdf)

čeština (CS) (1.75 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/cs/documents/product-information/repso-epar-product-information_cs.pdf)

dansk (DA) (1.01 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/da/documents/product-information/repso-epar-product-information_da.pdf)

Deutsch (DE) (1.01 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/de/documents/product-information/repso-epar-product-information_de.pdf)

eesti keel (ET) (974.29 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/et/documents/product-information/repso-epar-product-information_et.pdf)

ελληνικά (EL) (2.16 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/el/documents/product-information/repso-epar-product-information_el.pdf)

français (FR) (1.03 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/fr/documents/product-information/repso-epar-product-information_fr.pdf)

hrvatski (HR) (1.04 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/hr/documents/product-information/repso-epar-product-information_hr.pdf)

íslenska (IS) (989.95 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/is/documents/product-information/repso-epar-product-information_is.pdf)

italiano (IT) (1.04 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/it/documents/product-information/repso-epar-product-information_it.pdf)

latviešu valoda (LV) (1.75 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/lv/documents/product-information/repso-epar-product-information_lv.pdf)

lietuvių kalba (LT) (1.04 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/lt/documents/product-information/repso-epar-product-information_lt.pdf)

magyar (HU) (1.71 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/hu/documents/product-information/repso-epar-product-information_hu.pdf)

Malti (MT) (1.76 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/mt/documents/product-information/repso-epar-product-information_mt.pdf)

Nederlands (NL) (1.02 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/nl/documents/product-information/repso-epar-product-information_nl.pdf)

norsk (NO) (986.17 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/no/documents/product-information/repso-epar-product-information_no.pdf)

polski (PL) (1.81 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/pl/documents/product-information/repso-epar-product-information_pl.pdf)

português (PT) (1.07 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/pt/documents/product-information/repso-epar-product-information_pt.pdf)

română (RO) (1.22 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/ro/documents/product-information/repso-epar-product-information_ro.pdf)

slovenčina (SK) (1.75 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/sk/documents/product-information/repso-epar-product-information_sk.pdf)

slovenščina (SL) (1.65 MB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/sl/documents/product-information/repso-epar-product-information_sl.pdf)

Suomi (FI) (1007.85 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/fi/documents/product-information/repso-epar-product-information_fi.pdf)

svenska (SV) (982.67 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

21/04/2016

[View](/sv/documents/product-information/repso-epar-product-information_sv.pdf)

**Latest procedure affecting product information:** IA/0020 30/03/2016

icon globe

<!-- image -->

This medicine's product information is available in all **official EU languages** . Select 'available languages' to access the language you need.

Product information documents contain:

- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).

Repso : EPAR - All Authorised presentations

English (EN) (495.26 KB - PDF)

**First published:** 28/03/2011

**Last updated:** 28/03/2011

[View](/en/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_en.pdf)

[Other languages (24)](#file-language-dropdown-585)

български (BG) (540.85 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/bg/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_bg.pdf)

español (ES) (485.52 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/es/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_es.pdf)

čeština (CS) (525.45 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/cs/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_cs.pdf)

dansk (DA) (490.2 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/da/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_da.pdf)

Deutsch (DE) (484.5 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/de/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_de.pdf)

eesti keel (ET) (485.22 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/et/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_et.pdf)

ελληνικά (EL) (541.37 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/el/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_el.pdf)

français (FR) (482.39 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/fr/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_fr.pdf)

hrvatski (HR) (41.91 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/hr/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_hr.pdf)

íslenska (IS) (492.98 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/is/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_is.pdf)

italiano (IT) (484.58 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/it/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_it.pdf)

latviešu valoda (LV) (534.71 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/lv/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_lv.pdf)

lietuvių kalba (LT) (521.67 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/lt/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_lt.pdf)

magyar (HU) (527.71 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/hu/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_hu.pdf)

Malti (MT) (540.38 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/mt/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_mt.pdf)

Nederlands (NL) (483.86 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/nl/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_nl.pdf)

norsk (NO) (485.2 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/no/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_no.pdf)

polski (PL) (513.48 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/pl/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_pl.pdf)

português (PT) (485.71 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/pt/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_pt.pdf)

română (RO) (508.64 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/ro/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_ro.pdf)

slovenčina (SK) (539.12 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/sk/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_sk.pdf)

slovenščina (SL) (499.41 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/sl/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_sl.pdf)

Suomi (FI) (485.46 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/fi/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_fi.pdf)

svenska (SV) (485.5 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/sv/documents/all-authorised-presentations/repso-epar-all-authorised-presentations_sv.pdf)

Repso : EPAR - Conditions imposed on member states for safe and effective use - Annex IV

English (EN) (475.77 KB - PDF)

**First published:** 28/03/2011

**Last updated:** 28/03/2011

[View](/en/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_en.pdf)

[Other languages (23)](#file-language-dropdown-298)

български (BG) (582.9 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/bg/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_bg.pdf)

español (ES) (477.42 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/es/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_es.pdf)

čeština (CS) (628.32 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/cs/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_cs.pdf)

dansk (DA) (476.5 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/da/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_da.pdf)

Deutsch (DE) (476.89 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/de/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_de.pdf)

eesti keel (ET) (476.91 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/et/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_et.pdf)

ελληνικά (EL) (579.38 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/el/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_el.pdf)

français (FR) (476.38 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/fr/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_fr.pdf)

íslenska (IS) (476.97 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/is/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_is.pdf)

italiano (IT) (477.44 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/it/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_it.pdf)

latviešu valoda (LV) (573.8 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/lv/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_lv.pdf)

lietuvių kalba (LT) (543.38 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/lt/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_lt.pdf)

magyar (HU) (566.87 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/hu/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_hu.pdf)

Malti (MT) (570.22 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/mt/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_mt.pdf)

Nederlands (NL) (477.61 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/nl/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_nl.pdf)

norsk (NO) (476.21 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/no/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_no.pdf)

polski (PL) (573.18 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/pl/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_pl.pdf)

português (PT) (478.3 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/pt/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_pt.pdf)

română (RO) (546.51 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/ro/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_ro.pdf)

slovenčina (SK) (568.43 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/sk/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sk.pdf)

slovenščina (SL) (570.63 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/sl/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sl.pdf)

Suomi (FI) (478.04 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/fi/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_fi.pdf)

svenska (SV) (476.57 KB - PDF)

**First published:**

28/03/2011

**Last updated:**

28/03/2011

[View](/sv/documents/conditions-member-states/repso-epar-conditions-imposed-member-states-safe-and-effective-use-annex-iv_sv.pdf)

## Product details

Name of medicine Repso Active substance leflunomide International non-proprietary name (INN) or common name leflunomide Therapeutic area (MeSH)

- Arthritis, Rheumatoid
- Arthritis, Psoriatic

Anatomical therapeutic chemical (ATC) code L04AA13

### Pharmacotherapeutic group

Immunosuppressants

### Therapeutic indication

Leflunomide is indicated for the treatment of adult patients with:

- active rheumatoid arthritis as a 'disease-modifying antirheumatic drug' (DMARD);
- active psoriatic arthritis.

Recent or concurrent treatment with hepatotoxic or haematotoxic DMARDs (e.g. methotrexate) may result in an increased risk of serious adverse reactions; therefore, the initiation of leflunomide treatment has to be carefully considered regarding these benefit / risk aspects.

Moreover, switching from leflunomide to another DMARD without following the washout procedure may also increase the risk of serious adverse reactions even for a long time after the switching.

## Authorisation details

EMA product number EMEA/H/C/001222

Generic

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see [Generic and hybrid medicines](/node/69107) .

Marketing authorisation holder

Teva B.V.

Swensweg 5

Marketing authorisation issued 14/03/2011 Withdrawal of marketing authorisation 19/07/2017 Revision 11

## Assessment history

Expand section

Collapse section

## Changes since initial authorisation of medicine

Repso : EPAR - Procedural steps taken and scientific information after authorisation

English (EN) (612.72 KB - PDF)

**First published:** 20/09/2011

**Last updated:** 21/04/2016

[View](/en/documents/procedural-steps-after/repso-epar-procedural-steps-taken-and-scientific-information-after-authorisation_en.pdf)

## Initial marketing authorisation documents

Repso : EPAR - Public assessment report

Adopted

Reference Number: EMA/79461/2011

English (EN) (786.81 KB - PDF)

**First published:** 28/03/2011

**Last updated:** 28/03/2011

[View](/en/documents/assessment-report/repso-epar-public-assessment-report_en.pdf)

CHMP summary of positive opinion for Repso

Adopted

Reference Number: EMA/CHMP/605155/2010

English (EN) (514.08 KB - PDF)

**First published:** 17/12/2010

**Last updated:** 17/12/2010

[View](/en/documents/smop-initial/chmp-summary-positive-opinion-repso_en.pdf)

**This page was last updated on** 21/04/2016

## Share this page

[Back to top](#main-content)